Showing results (111-120 of 170) with videos related to
Sort By:
Pageof 17
Psychological Medicine|March 17, 1999
Psychometric properties of the Liebowitz Social Anxiety ScaleR G Heimberg, K J Horner, H R Juster, et al.The American Journal of Psychiatry|March 1, 1987
Discontinuation of alprazolam treatment in panic patientsA J Fyer, M R Liebowitz, J M Gorman, et al.The Journal of Neuropsychiatry and Clinical Neurosciences|January 1, 1992
Open trial of intravenous clomipramine in five treatment-refractory patients with obsessive-compulsive disorderB A Fallon, R Campeas, F R Schneier, et al.Journal of Clinical Psychopharmacology|February 1, 1986
Alprazolam in the treatment of panic disordersM R Liebowitz, A J Fyer, J M Gorman, et al.Psychiatry Research|January 1, 1985
Normalization of venous pH, pCO2, and bicarbonate levels after blockade of panic attacksJ M Gorman, A J Fyer, D C Ross, et al.Archives of General Psychiatry|January 1, 1988
Ventilatory physiology of patients with panic disorderJ M Gorman, M R Fyer, R Goetz, et al.Depression and Anxiety|January 1, 1997
Discriminating between generalized anxiety disorder and anxiety disorder not otherwise specified in a Hispanic population: is it only a matter of worry?L L Street, E Salman, R Garfinkle, et al.The American Journal of Psychiatry|April 1, 1995
Persistence of blunted human growth hormone response to clonidine in fluoxetine-treated patients with panic disorderJ D Coplan, L A Papp, J Martinez, et al.Psychiatry Research|May 1, 1987
Pituitary adrenocortical unresponsiveness in lactate-induced panicA P Levin, A R Doran, M R Liebowitz, et al.Journal of Clinical Psychopharmacology|December 1, 1989
Fluoxetine treatment of obsessive-compulsive disorder: an open clinical trialM R Liebowitz, E Hollander, F Schneier, et al.Pageof 17